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The resemblance between retrotransposons and retrovuuses suggests an evolutionary relationship and indtcates that they may share common 
transcription factors. We have analyzed the behaviour of the Drosophdu 1731 retrotransposon promoter in the human monocytic U937 cell line. 
We show that the long terminal repeat (LTR) of 1731 promotes CAT (chloramphemcol acetyl transferase) activity in these cells, in which it IS 
enhanced by phorbol esters. Using gel mobility assays, we detected a human nuclear protein that bmds m the U3 region of the LTR in a 
sequence-specific manner. Its precise target was determined by a DNase I footprinting experiment. 
Retrotransposon 173 1; Drosophilu mekmoguster; U937; Chloramphenicol acetyl transferase 
1. INTRODUCTION 
Retrotransposons are mobile genetic elements inte- 
grated in the genome of all eukaryotes examined so far 
as, for example, the Ty elements of yeast, the copia 
element of Drosophila, the intracisternal type A parti- 
cles of rodents and the THE1 repeats of humans (see 
[l-5] for reviews). Their similarities with retroviruses, as 
well as the mutations they may induce, justify increasing 
development of their study. 
Retrotransposons are usually classified into two 
groups with regard to the functional organization of 
their pol gene [6,7]. 1731 is a Drosophila mekmogaster 
retrotransposon which belongs to the Tyl-copia group 
[8,9]. It is 4,648 bp long and moderately repeated in the 
genome of the fly as well as in Drosophila cultured cells. 
The two 336 bp long terminal repeats (LTRs) of 1731 
exhibit the typical U3-R-U5 architecture of provirus 
LTRs, and the internal sequence encodes a gag and a 
pol gene. Expression of the pol gene in bacteria has 
shown that it encodes an authentic reverse transcriptase 
activity [lo]. As with other retrotransposons of the Tyl- 
copia group, a typical env gene was not detected in the 
1731 element. The unidirectional transcription of 1731 
is promoted by the 5’ LTR and generates a major pol- 
yadenylated RNA corresponding to the whole element. 
1731 is an especially attractive model for a molecular 
analysis of regulatory mechanisms because of its dual 
and opposite regulation by heat shock and steroids 
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[9,11,12]: 1731 expression has indeed been shown to be 
induced by heat shock and repressed by 20-hydroxye- 
cdysone (20-OH), the steroid hormone controlling in- 
sect molts. A functional analysis of the 5’ LTR has 
revealed three different parts [ll]: the ‘core promoter’ 
(positions -110 to +89 with respect to the initiation of 
transcription), followed by a silencer (positions +90 to 
+168), and preceded by a transcriptional activator (po- 
sitions -168 to -111). This last fragment includes two 
imperfect direct repeats, and the more proximal one 
with respect to the TATA box strongly activates the 
core promoter. This short segment (-140 to -111). 
named El, was shown to be involved in hormone and 
heat-shock regulation [l 1 ,121. 
The striking resemblance between retrotransposons 
and retroviruses suggests some evolutionary link be- 
tween them. and it was assumed that retroviruses may 
have derived from retrotransposons by the mere acqui- 
sition of a functional env gene or vice versa [ 131. Recent 
developments of PCR methods allowed a systematic 
search for retrotransposons through a number of 
genomes, using conserved sequences of the reverse tran- 
scriptase domains [14-181. New retrotransposons with 
high levels of similarity were thus found in very distant 
species. One disconcerting example is the existence of a 
retrotransposon very akin to 173 1 in the herring, Clupeu 
hurengus [14]. The persistance of sequence homology in 
such distant species, despite the fact that reverse tran- 
scription usually introduces numerous errors, seems to 
plead in favor of horizontal transmission [6,7,14,15,17, 
191. These works approach the evolutionary history of 
retrotransposons considering the conservation of the 
reverse transcriptase domain. We assumed that, if hori- 
zontal transmissions have really occurred, the transcrip- 
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Fig. 1 (A) Schematic represent&Ion of the 1731 LTR U3 region. + 1 refers to the transcrlptlon start. The sequence of the A and B ohgonucleotldes 
used in the gel retardation experiments 1s specified. (B) SchematIc representation of the pCATl21731 subclones used m transfectlon assays [ll]. 
PolyA SV40. simian virus 30 polyadenylatlon site. 
tional and translational machinery of the recipient host 
had to be efficient on the exogenous element, and it is 
therefore expected that traces persist at the functional 
level. It would mean that targets for ubiquitous transac- 
tivators might be conserved. It can be illustrated, for 
instance, by the fact that 1731 LTRs display several 
putative targets for vertebrate DNA binding factors. 
The U3 part of LTR contains sequences similar to the 
glucocorticoid receptor binding site [9,1 l] and to the 
NFKB binding site [l 11. This led us to think that some 
1731 promoter activity might be kept even in distant 
animal species. 
In the present paper, we analyze the behavior of the 
173 1 promoter after transfer to human monocytes. Our 
results show that a heterologous promoter, coming 
from a species as distant from human as is the fly, 
Drosophila. remains able to use for its benefit the host 
transcriptional and translational machinery. We also 
characterized a nuclear monocytic factor that binds se- 
quence-specifically the U3 region of the 1731 LTR. 
2. MATERIALS AND METHODS 
The plasmids D3 and LZ. were used throughout these experiments 
[I I]. Briefly. D3 conlams the 1731 core promoter (positions -110 to 
+89) subcloned into the pCATl2 vector. A synthetic ohgonucleotide 
corresponding Lo positions -140 to -111 of the LTR (I.e. El. the 
proximal repeat that has a strong activator role on the 1731 core 
promoter) was inserted upstream of the core promoter in D3. generat- 
mg plasmid L? (Fig. 1) The pCMV-CAT plasmid [‘O]. a kmd gift of 
Dr N. Israg]. was used as the transfectlon control 
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The human hlstlocytic lymphomacell hne. U937. a morphologically 
monocyte-like cell hne (a kind gift of Prof. D. Zagury) was used [21]. 
Cells were gro\rn m RPM1 1640 supplemented with fetal calf serum 
(5% v/c 1. I.-glutamme (2 mM) and antlblotlcs (pemcilhn 100 IU/ml: 
streptomycin 100 pg/ml). Transfections were performed by electropo- 
ratlon (CellJect; Eurogentec) [Xl. 30 lOh cells were centrifuged 
(1,000 x g; 5 mm) and resuspended m RPM1 1640 ulthout fetal calf 
serum. They Rere then transferred m an electrophoresls cu\ette and 
30 fig of supercoIled DNA was added. A simple pulse (capacltancr. 
l.SOOpF: voltage. 250 V; pulse time. 40-50 ms) has apphed. The cells 
were then transferred to 10 ml of growth medium and Incubated at 
37”C/5% CO, before being collected 40 h later. Phorbol ester treat- 
ment has performed m some experiments by addmg 50 ng/ml of PMA 
(phorbol 12-myrlstate 13-acetate; Sigma) and 5 pgiml of PHA 
(phytohemagglutinm; Sigma) 20 h before collcctmg the cells [23]. 
7.3 Chloruntpherttcoi uwtyl trunaftrusr ( CA TJ a.5 UI~F 
CAT assays were performed as previously described [1 I]. Protein 
concentrations were determmed by the method of Bradford using the 
Bio-Rad protein assay. IO-10 ,Q of proteins ( 173 1 plasmlds) or 0.5 pug 
of proteins (CMV plasmid) were used for the assay. The enzymatic 
reaction was stopped after 4 h and chloramphemcol and Its acetylated 
forms were separated by thm layer chromatography. Results were 
expressed as the percentage of the acetylated form per mg nf protein 
per h. 
The ohgonucleotides A (upper strand: 5’-TGTTGAATATA- 
GGCAATTTCCACATGTGCA-3’) and B (upper strand. 5’-TATG- 
TAATTTTGTATGAGAACATACATACATACACATG-3’) corre- 
sponding to positions -140 to -111 and -110 to -73 of the 1731 LTR, 
respectively. were used in gel retardation experiments. Nuclear ex- 
tracts. heparm agarose chromatography. and DNA-protein bmding 
assays were performed as previously described [24] usmg double- 
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stranded somcated herring sperm DNA as the non- specific competi- 1731 is able to keep its promoter function in a mon- 
tor. ocyte-like human cell line. 
2.5. DNase Ifootpruzting 
The binding reaction was performed as described above and care 
was taken that enough protein extract was used for complexing all the 
probe. After addition of an equal volume of 5 mM CaC12/10 mM 
MgCl:, DNase I digestion was carried out by adding 1 ~1 of DNase 
I (Boehringer) as indicated in the legend of the figure. After 1 min at 
room temperature. the reaction was stopped by the addition of 2.5 ~1 
of 250 mM EDTA. The samples were ethanol-precipitated and loaded 
on a 15% acrylamide/urea sequencing gel. 
We also analyzed the effect of the 28 bp activator 
repeat, El, on the level of CAT activity. An average of 
a 3-fold enhancement of the 1731 core promoter in the 
presence of this short sequence (plasmid L2) was ob- 
served, suggesting that DNA binding factors may inter- 
act with this segment of the LTR to enhance CAT ex- 
pression. 
3. RESULTS 
3.1. Activity of the 1731 promoter in human cells 
To determine whether the 1731 core promoter could 
be functional in human cells, we first realized transfec- 
tions of D3 plasmid in U937 cells by electroporation. 
The CMV-CAT plasmid was used as a transfection effi- 
ciency control in all the experiments. 
It was clearly shown that the 1731 core promoter is 
able to promote CAT (chloramphenicol acetyl trans- 
ferase) activity in human U937 cells. The CAT activity 
induced by the 1731 core promoter is about 400-fold 
lower than that of CMV. These results allow us to con- 
clude that the LTR of the invertebrate retrotransposons 
Phorbol esters have been well known to be mitogenic 
agents that activate a large range of transcription fac- 
tors. We tested the level of CAT activity in the presence 
or absence of PHA and PMA mitogens. The CAT activ- 
ity of the D3 and L2 plasmids was significantly induced 
by PHA/PMA (20 h treatment). An average of 5-fold 
and lo-fold enhancement by phorbol ester treatment 
was obtained with D3 and L2, respectively. 
These results are summarized on Fig. 2. They suggest 
that transactivating factor(s) activated by phorbol es- 
ters can modulate the 1731 promoter in human cells. 
3.2. In vitro binding of U937 cell proteins to the 1731 
LTR 
Since the 1731 promoter can induce a CAT activity 
A 
PMA/PHA - 
treatment CL- 
CMV D3 LP 
B- 
10 
5 
1 ,-I 
? ? 
D3 L2 
Fig. 2. Transfection of D3 and L2 subclones of 1731 in U937 cells. (A) Autoradiogram correspondmg to CAT assays from a representative 
transfection with (+) or without (-) PMPJPHA treatment. (B) Diagram representing the average of six independent experiments. CAT assays were 
performed 40 h after transfection and CAT reactions were allowed to contmue for 2 h with 0.05 /g or 10 pg of protein for CMV-CAT or 173 1 -CAT 
plasmids, respectively. The relative CAT activity was calculated by normalizing the percent conversion of chloramphenicol to its acetyl derivatives 
taking arbitrarily the results obtamed for D3 without treatment as equal to 1. 
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Fig. 3. Gel retardation assays using the A and B oligonucleotides as probes with U937 cell nuclear extracts. (A) Detection of complexes 1 and II 
with the A probe. The protein concentratton was increased from 0.5 to 3 fig per 23 ~1. The same pattern was obtained with the B ohgonucleottde 
as a probe (not shown). (B) Self-competttion experiments usmg 1 fig of protein. Molar excesses of competitor were added as indicated. Lanes 1-6, 
A probe; lanes 7-12, B probe. 
in human U937 cells, and is sensitive to phorbol ester 
treatment, we looked for DNA binding protein(s) able 
to bind, in a sequence-specific manner, the 1731 pro- 
moter upstream sequences. For this purpose, we used 
in gel retardation assays several oligodeoxynucleotides 
covering the region located upstream of the TATA box. 
Two oligonucleotides named A (i.e. El: including posi- 
tions - 140 to - 111) and B (covering positions - 110 to 
-73) were used throughout these experiments (see Fig. 1). 
Nuclear extracts were prepared from U937 human 
cells and assayed for DNA binding activity. They con- 
tain a factor that retards the movement of the probe 
through the gel and gives rise to two retarded bands, I 
and 11, with both oligonucleotides A and B (Fig. 3). 
Increasing the concentration of proteins in the gel-shift 
assay reveals the faster migrating band then the slower 
one, which suggests that I and II might correspond to 
monomer and dimer forms of the same proteic factor 
(Fig. 3A). To test the specificity of the interaction, bind- 
ing competition analyses were performed. The retarded 
complexes were abolished in the presence of an excess 
of unlabeled self-competitor: 50% competition was ob- 
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A Upper strand Lower strand 
A 
B- 
5’-TATGT~T~GTATGA GCA-3’ 
3”-#TACATTAAA+CATACT CGT-5’ 
-110 -100 -90 -80 
Fig. 4. DNase I prote~tlon analysis. (A) Protection of oligonucleotide B with factor 0.3 (1.e. eluted m the 0.3 M KC1 fraction of the heparin-agarose 
column). Both strands of the oligonucleotide were aiternatefy labeled as indicated. A-i-G, Maxam and Gilbert sequencing reactions carried out on 
the two strands for orientation. Lanes 1 and 5, patterns of DNase I cleavage in absence of proteins. Lanes 2 and 6. 3 and 7, 4 and 8, pattern of 
DNase I cleavage after binding reaction with the 0.3 M KC1 fraction in the presence of 4 ng of DNase I per ~1 and 1 8 (lanes 2 and S), 2.4 (lanes 
3 and 9), 3 (lanes 4 and IO), 3.6 (lanes S and 11) and 4.2 (lanes 6 and 12) pg of proteins. (B) Summary of the results shown in panel A Numbers 
indicate the posttion regarding the transcription initiation sne (+l). 
tained with about 30 molar excess of self-competition 
for A and 35 molar excess of self-competition for B (Fig. 
3B). These results indicate that the binding is specific. 
The specific complexes obtained with the A or B probes 
were also competed with by adding molar excess of B 
and A competitor, respectively (not shown), indicating 
that the same factor binds to both oligonucleotides. 
3.3. DNase Iprotection 
In order to identify this factor, its binding site was 
delineated by DNase I protection analysis. The factor 
was partially purified by heparin-agarose chromatogra- 
phy where it was eluted at about 0.3 M KCI. This frac- 
tion was then used to carry out the DNase I protection 
analysis using oligonucleotide B alternately labeled on 
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the top or the bottom strand. Results are shown in Fig. 
4. The binding site of this factor on oligonucleotide B 
comprises sequence -91 to -77. Comparison of this 
sequence with oligonucleotide A that also binds this 
factor, suggests the existence of another binding site at 
position -135 to -117, the binding consensus being 
APyNTNCAPyAPyPuTPuCA. where Py is C or T. Pu 
is A or G, and N is one of the four bases. Protection 
experiments with the whole LTR (not shown) confirmed 
this result. Comparison of this 15 nucleotide sequence 
with the TFD and GNOMIC databases using the SIG- 
NUC program [34] does not reveal any striking similar- 
ity with known nucleic signals. 
4. DISCUSSION 
Transposable elements are vertically transmitted as 
classical genetic information from parents to offspring, 
but horizontal transfer has also been argued [14-171, 
and even the possibility of interspecies transmission 
cannot be excluded. 
This paper reports the ability of a Drosophila retro- 
transposon promoter to function in a human monocyte- 
like cell line. Our experiments also describe the detec- 
tion of at least one proteic factor that specifically inter- 
acts with the 173 1 LTR in vitro. The DNA binding site, 
as compared to nucleic signal databases. does not allow 
the assimilation of this factor to any known transcrip- 
tion factor but it might represent the phorbol ester- 
activated protein present in U937 cells. Further experi- 
ments are needed to test this hypothesis. 
This work should be considered as an initial attempt 
at identifying trans-activating factors that interact. in an 
heterologous system. with a Drosoplziln retrotransposon 
promoter: it should be placed in an evolutionary context 
indicating that the use of a heterologous molecular ma- 
chinery is not a barrier to interspecies transmission of 
retrotransposons. Furthermore. heterologous transfec- 
tion appears to be a good experimental system to define 
the common mechanisms controlling retrovirus and 
retrotransposon promoter activity and to establish their 
evolutionary link. Although retrotransposons have not 
been further demonstrated to be infectious, mostly be- 
cause of the absence of an env gene, they might be, 
under some conditions. 1731 comprises. for example, a 
third open reading frame, just upstream the 3’ LTR. the 
sequence of which does not include any env gene. Trans- 
lation of a reporter gene when introduced into this third 
ORF was shown to be possible (C. Coulondre and M. 
Best-Belpomme, in preparation). On the one hand, this 
third ORF can be considered as a vestige of an ancestor 
env gene; but on the other hand, one can imagine that 
setting up the env gene in frame with this ORF could 
restore the infectiousness. 
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